TSMC Could Swing $150 Billion as Options Market Prices Big Moves for This Week’s Earnings

Earnings season kicks into high gear next week, with a slate of heavyweight companies set to report quarterly results between July 12 and July 18.

As investors look for fresh insight into corporate earnings, guidance and the broader economic backdrop, options traders are already betting on how sharply these stocks could move once the numbers are released.

The options market is pricing in significant post-earnings volatility across sectors ranging from banking and healthcare to semiconductors and streaming, setting the stage for a week that could generate some of the biggest single-stock moves of the quarter.

Read Also: Meta Could Face Billions in Fines as EU Cracks Down on 'Addictive' Facebook and Instagram Features JPMorgan Opens Earnings Week JPMorgan Chase & Co. (NYSE: JPM ) reports second-quarter 2026 results Tuesday before the opening bell.

Analysts expect $5.59 in EPS on $49.39 billion in revenue, up from $4.96 on $45.68 billion a year ago.

Pro data show options pricing in a 3.87% move — the smallest on this list — which still equates to $34.9 billion of market value at stake given JPMorgan’s $903 billion market cap.

JPMorgan runs one of the world’s largest financial platforms, with a $4.9 trillion balance sheet and $2.68 trillion in deposits as of March.

The stock holds a Buy consensus rating and trades above its average price forecast.

In July, both B of A Securities and UBS reiterated Buy ratings and raised their targets.

Shares are up 3.4% year-to-date in 2026, trading 9.0% above the 200-day moving average and within 1.9% of the 52-week high of $343.45.

Johnson & Johnson — Healthcare Earnings Spotlight Johnson & Johnson (NYSE: JNJ ) reports second-quarter 2026 results Wednesday before the opening bell.

Consensus estimates call for $2.85 in EPS on $25.05 billion in revenue, compared with $2.77 on $23.74 billion a year earlier.

The options market is pricing in a 4.13% move, according to Pro — about $25.8 billion of market value at stake as investors weigh how the quarter lands across the company’s two remaining business pillars.

J&J is now a pure-play across innovative medicine and medtech following its 2023 consumer-health spinoff.

The stock holds a Buy consensus rating and trades above its price forecast.

Morgan Stanley and Citigroup both reiterated bullish ratings in July while raising their targets.

Shares are up 24.6% year-to-date in 2026, trading 17.2% above the 200-day moving average and about 68% above the 52-week low of $154.21.

GE Tests Aerospace Demand GE Aerospace (NYSE: GE ) reports second-quarter 2026 results Thursday before the opening bell.

Analysts expect $1.85 in EPS on $11.79 billion in revenue, versus $1.66 on $11.02 billion a year ago.

Options are pricing in a 5.89% move, putting roughly $22 billion of market value at stake.

For a company tied closely to commercial engine demand and servicing trends, that signals the market expects a meaningful reaction to both results and forward guidance.

GE Aerospace designs, manufactures, and services commercial aircraft turbine engines, including through its CFM joint venture with Safran.

The stock carries a Buy consensus rating and trades above its average price forecast.

Susquehanna, Jefferies and Citigroup all raised their price forecasts in July.

Shares are up 11.1% year-to-date in 2026, trading 14.8% above the 200-day moving average and about 47% above the 52-week low of $243.34.

UnitedHealth Group UnitedHealth Group Incorporated (NYSE: UNH ) reports second-quarter 2026 results Thursday before the opening bell.

Consensus calls for $4.85 in EPS on $110.77 billion in revenue, compared with $4.08 on $111.62 billion a year ago.

Pro shows a 6.06% implied move, with $23.5 billion of market value at stake.

The setup stands out because revenue is expected to dip slightly year-over-year even as EPS rises — a mix that could sharpen focus on medical-cost trends this quarter.

UnitedHealth is one of the largest private health insurers globally, covering about 51 million members as of December 2025.

The stock carries a Buy consensus rating and trades above its average price forecast.

RBC Capital reiterated Outperform and raised its target in July, while HSBC reiterated Hold and also raised its forecast.

Shares are up 26.8% year-to-date in 2026, trading 25.8% above the 200-day moving average and within 1.7% of the 52-week high of $434.30.

TSMC Leads Market Mover s Taiwan Semiconductor Manufacturing Company Ltd. (NYSE: TSM ) reports second-quarter 2026 results Thursday before the opening bell.

Wall Street is modeling $3.77 in earnings per share on $39.76 billion in revenue, up sharply from $2.47 on $30.07 billion a year ago.

Options are pricing in a 6.65% move, according to Pro — and at this size, the dollar stakes are enormous: roughly $150 billion of market value hangs in the balance.